Cargando…
Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
Melanoma is an immunogenic tumor and a serious type of skin cancer. Tumor-associated macrophages (TAMs) express an M2-like phenotype and are involved in all stages of melanomagenesis; it is hence a promising target for cancer immunotherapy. We herein investigated whether melittin–dKLA inhibits the g...
Autores principales: | Han, Ik-Hwan, Jeong, Chanmi, Yang, Juwon, Park, Seung-Hyeok, Hwang, Deok-Sang, Bae, Hyunsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954064/ https://www.ncbi.nlm.nih.gov/pubmed/35328518 http://dx.doi.org/10.3390/ijms23063094 |
Ejemplares similares
-
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Kim, Soyoung, et al.
Publicado: (2022) -
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
por: Lee, Chanju, et al.
Publicado: (2022) -
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages
por: Jeong, Chanmi, et al.
Publicado: (2023) -
Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
por: Lee, Chanju, et al.
Publicado: (2019) -
TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Lee, Chanju, et al.
Publicado: (2022)